Bildkälla: Stockfoto

Xspray Pharma: Robust Finances – Directed Share Issue Raised SEK 100m - Redeye

Redeye positively views yesterday evening’s news that Xspray, through a directed share issue, has secured SEK 100m in funding, targeting its largest owners and new institutional capital. We leave a comment and adjust our fair value range for the dilution.

Redeye positively views yesterday evening’s news that Xspray, through a directed share issue, has secured SEK 100m in funding, targeting its largest owners and new institutional capital. We leave a comment and adjust our fair value range for the dilution.
Börsvärldens nyhetsbrev
ANNONSER